All In Biotech

Free tool

FAERS Monitor: Spiriva Respimat

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021936 or its brand name (Spiriva Respimat, Tiotropium Bromide). Reports on generic versions are filed under their own applications.

Reports

11,487

Serious

6,855

60% of reports

Hospitalization

3,719

Death reported

778

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • dyspnoea2,340
  • asthma1,510
  • cough1,093
  • pneumonia934
  • wheezing846
  • drug ineffective771
  • off label use716
  • therapeutic product effect incomplete581
  • chronic obstructive pulmonary disease570
  • loss of personal independence in daily activities520
  • fatigue508
  • headache469
  • sleep disorder due to a general medical condition444
  • death425
  • malaise412

Reports by year received

View as table
YearReports
20083
20093
201013
201124
201242
201375
201431
201550
2016121
2017418
20181,080
20191,223
20201,652
20211,213
20221,006
20231,000
20241,273
20251,209
20261,051

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,042,672 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
sleep disorder due to a general medical conditionSignal44449.144.820,356
wheezingSignal84626.524.820,483
asthmaSignal1,51024.823.634,162
chronic obstructive pulmonary diseaseSignal57020.218.610,302
loss of personal independence in daily activitiesSignal52020.018.49,301
therapeutic product effect incompleteSignal58115.113.97,581
dyspnoeaSignal2,3407.67.313,710
coughSignal1,0937.26.85,842
pneumoniaSignal9345.35.03,291
malaise4121.71.6126
off label use7161.51.4123
headache4691.41.348
fatigue5081.21.117
drug ineffective7711.11.04
death4250.90.84

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.